Smith Lon L - OmicsDI

Show results for

Unknown (19)
Genomics (14)
Transcriptomics (4)
Metabolomics (3)

Organisms

Homo sapiens (13)
Streptomyces coelicolor (4)
Escherichia coli str. K-12 substr. MG1655 (1)

Repository

EGA (13)
biostudies-arrayexpress (5)
MetaboLights (3)

Technology Type

Illumina 15K (8)
Mass spectrometry (2)
Mass spectrometry assay (1)

Instrument Platform

Illumina NovaSeq 6000 (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - alternating - reverse-phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2009 (4)
2026 (2)
2025 (2)

Metabolite Name

(+)-Prosopinine (1)
(+/-)-Bocconarborine A (1)
(+/-)-Bocconarborine B (1)
(1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (1)
(1-hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone (1)
(10)-Gingerol (1)
(1R,12S,16Z,24E,26E,28Z,32S)-1,18-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0,]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone (1)
(1R,16Z,24E,26E,28Z)-1,18-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)propan-2-yl]-29-(hydroxymethyl)-19,30-dimethoxy-15,17,21,23,35-pentamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0,]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone (1)
(1R,2R,5Z,12R,13S,16Z)-25-(9H-pyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol (1)
(1R,2S,13S,16S,17S,19R,20R,22S,25S,27S)-1,2,24,24-tetramethyl-8,9-bis(3-methylbut-2-enyl)-22-(2-methylprop-1-enyl)-18,21,23,26-tetraoxa-4-azaoctacyclo[14.13.0.02,13.03,11.05,10.017,19.017,27.020,25]nonacosa-3(11),5(10),6,8-tetraen-16-ol (1)
(1R,2S,4S,6R,7S,8R,9S,12S,13S,18S)-6-methoxy-7,9,13-trimethyl-6-[(3S)-3-methyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-16-one (1)
(1R,3S,6S,7E,13S,16R,17R,21S,22S)-17-[(2R,4R,5S,6R)-5-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-28-hydroxy-3,22-dimethyl-23,26-dioxo-24,27-dioxapentacyclo[23.2.1.01,6.013,22.016,21]octacosa-4,7,14,25(28)-tetraene-4-carboxylic acid (1)
(1S,2R,4aR,6aS,6bR,12aS,12bR,14bR)-1,2,4a,6a,6b,9,12a-Heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,11,12,12a,12b,13,14b-octadecahydropicene (1)
(1S,2S,6R,7S,9R,10R,11R)-1,4,4-trimethyl-8,13-dioxatetracyclo[8.2.1.02,6.07,11]tridecane-9,10-diol (1)
(1S,3R)-5-[3-[4-[(1S,3R)-6,8-dihydroxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-5-yl]-1-hydroxy-8-methoxy-6-methylnaphthalen-2-yl]-4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl]-1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline-6,8-diol (1)
(1S,3Z,5R,7R)-3-[(3,4-dihydroxyphenyl)-hydroxy-methylene]-1-[(2S)-2-isopropenyl-5-methyl-hex-4-enyl]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)bicyclo[3.3.1]nonane-2,4,9-trione (1)
(1S,4R)-1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione (1)
(1aR,7aS,10aS,10bS)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one (1)
(2-Chloro-benzyl)-pyridin-3-ylmethyl-amine (1)
(2-Iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanone (1)
(2-methoxy-4-{2-[(1R,16Z,24E,26E,28Z)-1,18,19-trihydroxy-30-methoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0,]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl}cyclohexyl)oxidanesulfonic acid (1)
(2-{[3-(3,4-Dihydroxy-5-methoxyphenyl)prop-2-enoyl]oxy}ethyl)trimethylazanium (1)
(23S)-23,25,26-trihydroxycalciol (1)
(25S)-26-Hydroxy-24-methylenecycloartan-3-one (1)
(2R)-2-[(2R,3R,4S)-3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-hydroxyethyl dodecanoate (1)
(2R)-2-hydroxy-N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadeca-4,8-dien-2-yl]tetracosanamide (1)
(2R)-O-phospho-3-sulfolactic acid (1)
(2R,13R,14S,15S,17S)-17-hydroxy-2,13,14,15-tetramethyl-14-propanoyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one (1)
(2R,3S,5S,8R,9S,10S,13S,17R)-17-[(2S,3R,4R,5S)-3,4-dihydroxy-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-2,3-diol (1)
(2S)-2-[[(2R,3R)-3-azaniumyl-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoate (1)

Study type

Transcription profiling by array (4)
ChIP-seq (1)

Release Date

2009 (4)
2022 (4)
2016 (4)
2023 (2)
2021 (2)
2018 (2)
2011 (2)
2026 (1)
2024 (1)
2019 (1)
2015 (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

Bacteria encode their own post-mortem protein catabolism to enable nutrient recycling

For many organisms, death is a tangible, visible event. In bacteria, death can be a natural or an induced process 1. Death permits genes conferring a survival advantage to be selected in a bacterial population. Furthermore, biomolecule recycling from dead bacteria is crucial under nutrient limitatio...

2025-01-23 | MTBLS10044 | MetaboLights

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

Not available

S-EPMC3565012 | biostudies-literature

ChIP-seq experiment: DnaA binding to E. coli chromosome before stress, during stress, and stress recovery

The ubiquitous protein DnaA is a chromosomal DNA replication initiator and transcription factor. It binds to 9-bp DNA sites called \"DnaA-boxes\" that are localized within the replication origin (oriC) and throughout chromosomal DNA, usually in the proximity of the promoter regions. During stress, b...

ORGANISM(S): Escherichia coli str. K-12 substr. MG1655

2026-03-13 | E-MTAB-14964 | biostudies-arrayexpress

Chromatin immunoprecipitation of Streptomyces coelicolor HspR binding sites

Global ChIP-chip analysis of HspR repressor binding sites in Streptomyces coelicolor MT1110 cultures grown in YEME plus 10% sucrose at 30?C up to early stationary phase. Chromatin extracted from formaldehyde treated cultures was incubated with anti HspR polyclonal antibodies and the DNA purified f...

ORGANISM(S): Streptomyces coelicolor

2009-02-07 | E-MAXD-48 | biostudies-arrayexpress

Transcription profiling of Streptomyces coelicolor hspR mutant compared to wild-type strain

Global gene expression patterns of S. coelicolor MT1151 and MT1153 (two independent MT1110 hspR disruption mutants ) cultures compared to MT1152 and MT1154 (two independent isolates of hspR+ integrants), grown on SMMS agar medium for 36 h .

ORGANISM(S): Streptomyces coelicolor

2009-02-07 | E-MAXD-44 | biostudies-arrayexpress

Transcription profiling of Streptomyces coelicolor hspR+integrants of MT1110 after heat shock

Global gene expression patterns of MT1152 and MT1154 (two hspR+integrants of MT1110) grown on SMMS agar medium for 36 h and heat shocked at 42oC for 15 min. RNA was harvested from heat-shocked cultures and control cultures grown at 30oC and hybridized onto high density IJISS arrays to identify which...

ORGANISM(S): Streptomyces coelicolor

2009-02-07 | E-MAXD-46 | biostudies-arrayexpress

Transcription profiling of S. coelicolor grown in liquid culture and heat shock stimulated

Global gene expression patterns of two biological replicate cultures of S.coelicolor MT1110 grown on YEME plus 10% sucrose up to early stationary phase ( the culture conditions were the same used for obtaining ChIP-chip data with anti HspR antibodies). RNA was harvested from heat-shocked cultures ...

ORGANISM(S): Streptomyces coelicolor

2009-02-07 | E-MAXD-49 | biostudies-arrayexpress

Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial.

Not available

S-EPMC3094355 | biostudies-literature

Gametocyte Carriage, Antimalarial Use, and Drug Resistance in Cambodia, 2008-2014.

Not available

S-EPMC6221238 | biostudies-literature

Free fatty acid generation via Rhein-induced LDL-C endocytosis accelerates biofilm infected diabetic wound healing

Diabetic foot infection (DFI) significantly increases risks of hospitalization and amputation, with biofilm infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE) being key drivers of treatment failure. Here, we ana...

2026-01-06 | MTBLS13603 | MetaboLights

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

40 Results

Show results for

Organisms

Repository

Technology Type

Instrument Platform

Publication Date

Metabolite Name

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets